Electroclinical syndrome |
Gene
or CNV |
Associated features
(may not be present) |
Inherit |
Mutation
frequency |
Benign familial neonatal epilepsy |
KCNQ2 |
Myokymia (one family) |
AD |
80% |
|
KCNQ3 |
|
|
5% |
|
inv(5)(p15q11) |
|
|
1 family |
Benign familial neonatal-infantile
epilepsy |
SCN2A |
Earlier onset than BFIE, resolves by 12 months |
AD |
? 100% |
Benign familial infantile epilepsy |
PRRT2 |
Allelic with familial PKD/C |
AD |
83% |
|
ATP1A2 |
Allelic with familial hemiplegic migraine |
|
1 family |
|
KCNQ2 |
|
|
1 family |
Early myoclonic encephalopathy (EME) |
AMT |
Glycine encephalopathy |
AR |
|
AND |
GLDC |
Glycine encephalopathy |
AR |
|
Early infantile epileptic encephalopathy
with suppression-bursts (EIEE) |
GCSH |
Glycine encephalopathy |
AR |
|
AND |
PNPO |
PLP-dependent |
AR |
|
Infantile epileptic encephalopathy NOS |
ALDH7A1 |
B6-dependent, folinic acid responsive |
AR |
|
(Infantile epilepsies progressing to West
syndrome and Lennox-Gastaut syndrome included) |
BTD |
Biotinidase deficiency, skin changes (~10% only) |
AR |
|
|
MTHFR |
Elevated homocysteine, PV WM hyperintensities |
AR |
|
|
ATP7A |
low Cu2+, kinky hair, low CSF catecholamines |
X |
|
|
SUOX |
Sulfite oxidase deficiency |
AR |
|
|
MOCS1/2 |
Molybdenum cofactor deficiency |
AR |
|
|
GPHN |
Molybdenum cofactor deficiency |
AR |
|
|
PCCA/B |
Propionic acidaemia, myoclonus, photosensitivity |
AR |
|
|
GLYCTK |
D-glyceric acidaemia, glycine encephalopathy |
AR |
|
|
ARX |
Allelic with XLAG, dyskinesia, BG hyperintensities |
X |
7% |
|
CDKL5 |
Atypical Rett syndrome, normal early interictal EEG |
XD |
|
|
SLC25A22 |
Cerebellar hypoplasia, CC malformation |
AR |
|
|
STXBP1 |
|
AD |
6% |
|
SPTAN1 |
Cerebral atrophy, hypomyelination |
AD |
|
|
KCNQ2 |
Early (resolving) thalamic/BG hyperintensities |
AD |
|
|
ARHGEF9 |
Hyperpekplexia and epilepsy |
X |
|
|
PCDH19 |
Family history of epilepsy/MR limited to females |
X-L2F |
|
|
PNKP |
Congenital microcephaly, simplified gyri |
AR |
|
|
SCN2A |
Late episodic ataxia and myoclonus |
AD |
|
|
PLCB1 |
Allelic with MMPSI |
AR |
|
|
SCN8A |
|
AD |
|
|
SLC2A1 |
GLUT1-DS, FHx of paroxysmal exertional dystonia |
AD |
|
|
MECP2 |
Atypical Rett syndrome |
XD |
|
|
FOXG1 |
Atypical Rett syndrome |
AD |
|
Migrating focal seizures of infancy
(MMPSI) |
KCNT1 |
Delayed myelination, cortical atrophy, thin CC |
AD |
50% |
|
SCN1A |
|
AD |
13% |
|
PLCB1 |
|
AR |
2 cases |
|
TBC1D24 |
|
AR |
1 family |
West syndrome |
TSC1/2 |
Tuberous sclerosis |
AD |
20% |
(where onset of spasms without other prior
seizures is reported) |
ARX |
Allelic with XLAG, DD prior to ES, spasticity |
X |
|
|
CDKL5 |
Rare without prior seizures, DD prior to ES |
XD |
|
|
STXBP1 |
Rare without prior seizures |
AD |
|
|
ST3GAL3 |
No seizures prior to ES in all reported cases |
AR |
|
|
ADSL |
Urine SAICAR elevated, Angelman-like |
AR |
|
|
trisomy 21 |
Down syndrome |
|
|
|
del 7q11.23 |
Williams-Beuren syndrome |
|
|
|
dup FOXG1 |
Atypical Rett syndrome |
|
|
|
dup 16p11.2 |
|
|
|
|
?Xp22 |
Aicardi syndrome |
?XD |
|
Benign myoclonic epilepsy of infancy
(BMEI) |
TBC1D24 |
Familial infantile myoclonic epilepsy (FIME) |
AR |
|
Dravet syndrome (SMEI) |
SCN1A |
|
AD |
61-87% |
(SMEB included) |
SCN2A |
|
|
|
|
GABRG2 |
|
|
|
|
SCN8A |
|
|
|
|
PCDH19 |
Similar to Dravet syndrome (in some cases) |
X-L2F |
|
Febrile seizures (FS+ included) |
SCN1A |
|
AD |
|
|
SCN2A |
|
|
|
|
SCN1B |
|
|
|
|
GABRD |
|
|
|
|
GABRG2 |
|
|
|
|
PCDH19 |
Family history of epilepsy/MR limited to females |
X-L2F |
|
Epilepsy with myoclonic-astatic seizures
(MAE) |
SLC2A1 |
GLUT1-DS, PED, ataxia |
AD |
5% |
|
SCN1A |
|
AD |
|
Benign epilepsy with centrotemporal spikes
(BECTS/BFEC) |
- |
No concordance in MZ and DZ twins |
|
|
Atypical BFEC (CSWS/ESES and
Landau-Kleffner syndrome included) |
SRPX2 |
Rolandic epilepsy, speech dyspraxia (+/- PMG) |
X |
|
Childhood absence epilepsy (CAE) |
SLC2A1 |
10% of early onset cases (less than 4 years) |
AD |
|
|
GABRG2 |
|
AD |
|
|
GABRA1 |
|
AD |
|
|
CACNA1H |
Han Chinese, contributory in polygenic causaton |
|
|
Juvenile absence epilepsy (JAE) |
EFHC1 |
Familial GGE |
AD |
|
Juvenile myoclonic epilepsy (JME) |
SLC2A1 |
Familial GGE, paroxysmal exertional dystonia |
AD |
|
|
EFHC1 |
Familial GGE |
AD |
3-9% |
|
GABRA1 |
Familial JME |
AD |
|
|
CACNB4 |
GGE with episodic ataxia, acetazolamide responsive |
AD |
|
|
GABRD |
|
AD |
|
|
CLCN2 |
Implicated in other GGE but significance unknown |
AD |
|
Genetic generalised epilepsy (GGE) |
SLC2A1 |
Familial GGE, paroxysmal exertional dystonia |
AD |
1% |
(Phenotypes include CAE, JAE, JME, MAE,
FS+ and GGE NOS) |
CACNB4 |
GGE with episodic ataxia, acetazolamide responsive |
AD |
|
|
CACNA1A |
GGE, episodic ataxia, familial hemiplegic migraine |
AD |
|
|
CACNA1H |
variants contributory in up to 8% of patients |
|
|
|
del 15q13.3 |
|
|
1% |
|
del 16p13.11 |
|
|
1% |
|
del 15q11.2 |
|
|
1% |
Autosomal-dominant nocturnal frontal lobe
epilepsy (ADNFLE) |
CHRNA4 |
|
AD |
|
|
CHRNA2 |
|
AD |
|
|
CHRNB2 |
|
AD |
|
|
KCNT1 |
More severe with psychiatric features and ID |
AD |
|
Autosomal-dominant epilepsy with auditory
features (ADEAF) |
LGI1 |
|
AD |
50% |
Familial focal epilepsy with variable foci
(FFEVF) |
DEPDC5 |
Includes some familial TLE/FLE |
AD |
12-37% |
Epilepsy and autism/ID |
BCKDK |
Reduced plasma branched chain amino acids |
AR |
|
|
SYN1 |
|
X |
|
|
GRIN2A |
Epilepsy and mental retardation |
AR |
|